Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Neurol.

Sec. Applied Neuroimaging

Volume 16 - 2025 | doi: 10.3389/fneur.2025.1612379

Predictive Value of Cerebral Perfusion and Guanine Nucleotide-Binding Protein, Alpha-Stimulating Activity Polypeptide in Ischemic White Matter Lesions: A Machine Learning Approach

Provisionally accepted
Ning  YuNing Yu1,2*Shuai  MaShuai Ma3,4Zongkai  WuZongkai Wu5Zhijie  DouZhijie Dou1,2Shengxian  JiaoShengxian Jiao5Yajing  LiYajing Li1Hebo  WangHebo Wang5Xiaoxuan  ZhangXiaoxuan Zhang1*
  • 1Neurology Department, Affiliated Hospital of Chengde Medical University, Chengde, China
  • 2Hebei Key Laboratory of Nerve Injury and Repair, Chengde Medical University, Chengde, Hebei Province, China
  • 3Institute of Traditional Chinese Medicine, Chengde Medical University, Chengde, Shanghai Municipality, China
  • 4Hebei Province Key Laboratory of Traditional Chinese Medicine Research and Development, Chengde, China
  • 5Department of Neurology, Hebei General Hospital, Shijiazhuang, Hebei Province, China

The final, formatted version of the article will be published soon.

Purpose: To assess the predictive value of guanine nucleotide-binding protein, alpha-stimulating activity polypeptide (GNAS) and cerebral perfusion in various vascular regions for the severity of ischemic white matter lesions (WMLs). Methods: Patients hospitalized at the Neurology Department of the Affiliated Hospital of Chengde Medical University between April and November 2023 were evaluated for ischemic cerebral WMLs using magnetic resonance imaging. In this retrospective cohort study, patients were classified into two groups: mild and severe, based on Fazekas scores. White matter perfusion was assessed using image segmentation of arterial spin labeling sequence images. Predictive variables were identified via This is a provisional file, not the final typeset article machine learning (ML). GNAS levels in peripheral blood were measured to explore their association with WML severity. Results: Among 85 patients (43 mild [24 males and 19 females], 42 severe [27 males and 15 females]), significant differences were observed in age (64.00±8.47 years vs. 68.38±10.85 years, p=0.041), cerebral atrophy (37.2% vs. 71.4%, p=0.002), and history of hypertension (41.7% vs. 77.0%, p=0.002). Corpus callosum perfusion was lower in the severe group (35.84±6.34 vs. 31.73±8.60 ml/[min·100 g], p=0.037). ML yielded 77.27% model accuracy. Although no significant difference in GNAS levels was observed (p = 0.375), a significant difference was noted in the Fazekas scores (p < 0.001). Conclusion: In patients with ischemic WMLs, factors such as age, sex, history of cerebral infarction, GNAS levels, and specific perfusion metrics are predictive of WML progression. Advanced imaging and ML improve detection. GNAS levels correlated with Fazekas scores, indicating their downregulation in the hypoperfused white matter.

Keywords: cerebral perfusion, White matter lesion, Guanine nucleotide-binding protein, alpha-stimulating activity polypeptide, Arterial Spin Labeling

Received: 15 Apr 2025; Accepted: 09 Oct 2025.

Copyright: © 2025 Yu, Ma, Wu, Dou, Jiao, Li, Wang and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Ning Yu, laura_lover@qq.com
Xiaoxuan Zhang, 6401579@qq.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.